Search Results - Endovascular Today

evt | Article | July 2025

The 10 Fr Pounce™ Venous Thrombectomy System: Designed for power and operator control

With Stephen A. Black, MD; Pradeep K. Nair, MD; and Nachiket J. Patel, MD

evt | Article | December 2025 Supplement

The 10 Fr Pounce™ Venous Thrombectomy System: Designed for Power and Operator Control

With Stephen A. Black, MD, FRCS(Ed), FEBVS; Pradeep K. Nair, MD, FACC, FSCAI; and Nachiket J. Patel, MD, FACC, FACP, FSCAI

evt | Article | October 2016 Supplement

Diverse Applications for Turbo-Power Excimer Laser Atherectomy

Leading experts in the field present case reports and discuss the utility of excimer laser atherectomy in the SFA and popliteal arteries.

With Amjad Al Mahameed, MD, MPH; Pradeep K. Nair, MD, FACC, FSCAI; Craig Walker, MD; Vinayak Subramanian, BS; George L. Adams, MD, MHS; Sachin Kumar Amruthlal Jain, MD; Prakash Krishnan, MD, FACC, FSCAI; Fadi Saab, MD; and J.A. Mustapha, MD

evt | Article | May 2016

Diverse Applications for Turbo-Power Excimer Laser Atherectomy

Leading experts in the field present case reports and discuss the utility of excimer laser atherectomy in the SFA and popliteal arteries.

With Amjad AlMahameed, MD, MPH; Pradeep K. Nair, MD, FACC, FSCAI; Craig Walker, MD; Vinayak Subramanian, BS; George L. Adams, MD, MHS; Sachin Kumar Amruthlal Jain, MD; Prakash Krishnan, MD, FACC, FSCAI; Fadi Saab, MD; and J.A. Mustapha, MD

evt | News | November 6, 2018

Six-Month COPPER BTK Cohort Results Presented for the Occlusion Perfusion Catheter

November 7, 2018—The 6-month interim results from the COPPER below-the-knee (BTK) Cohort were presented by Pradeep K. Nair, MD, at VIVA 2018, the Vascular Interventional Advances annual conference held November 5–8 in Las Vegas, Nevada. The study is investigating the utilization of the Occlusion perfusion catheter (OPC, Advanced Catheter Therapies) to administer antiproliferative medications for peripheral artery disease (PAD). The study's objective was to assess the safety and efficacy of paclitaxel administration using the OPC drug-delivery catheter for the prevention of restenosis in infrapopliteal de novo and restenotic lesions.